InMed Pharmaceuticals
17 hedge funds and large institutions have $334K invested in InMed Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 2 closing their positions.
Holders
17
Holders Change
+7
Holders Change %
+70%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
–
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SM
1
Sabby Management
Miami Beach,
Florida
|
$213K |
| 2 |
AC
2
Armistice Capital
New York
|
$85.7K |
| 3 |
3
Renaissance Technologies
New York
|
$16K |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$14.1K |
| 5 |
TSS
5
Two Sigma Securities
New York
|
$5.36K |
